Logo image of JUPW

JUPITER WELLNESS INC (JUPW) Stock Fundamental Analysis

NASDAQ:JUPW - Nasdaq - US48208F1057 - Common Stock - Currency: USD

1.52  +0.16 (+11.76%)

After market: 1.5 -0.02 (-1.32%)

Fundamental Rating

2

JUPW gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. While JUPW seems to be doing ok healthwise, there are quite some concerns on its profitability. JUPW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year JUPW has reported negative net income.
In the past year JUPW has reported a negative cash flow from operations.
JUPW had negative earnings in each of the past 5 years.
In the past 5 years JUPW always reported negative operating cash flow.
JUPW Yearly Net Income VS EBIT VS OCF VS FCFJUPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -5M -10M -15M -20M -25M

1.2 Ratios

The profitability ratios for JUPW are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JUPW Yearly ROA, ROE, ROICJUPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 19.36%, JUPW is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for JUPW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JUPW Yearly Profit, Operating, Gross MarginsJUPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K

More info and screens

5

2. Health

2.1 Basic Checks

JUPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JUPW has been reduced compared to 1 year ago.
Compared to 1 year ago, JUPW has a worse debt to assets ratio.
JUPW Yearly Shares OutstandingJUPW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M 15M 20M
JUPW Yearly Total Debt VS Total AssetsJUPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -4.45, we must say that JUPW is in the distress zone and has some risk of bankruptcy.
JUPW has a worse Altman-Z score (-4.45) than 85.00% of its industry peers.
JUPW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.45
ROIC/WACCN/A
WACC9%
JUPW Yearly LT Debt VS Equity VS FCFJUPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.84 indicates that JUPW should not have too much problems paying its short term obligations.
JUPW has a Current ratio of 1.84. This is comparable to the rest of the industry: JUPW outperforms 52.50% of its industry peers.
A Quick Ratio of 1.77 indicates that JUPW should not have too much problems paying its short term obligations.
JUPW has a better Quick ratio (1.77) than 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.77
JUPW Yearly Current Assets VS Current LiabilitesJUPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

JUPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.65%, which is quite impressive.
The Revenue has been growing slightly by 0.13% in the past year.
Measured over the past years, JUPW shows a very strong growth in Revenue. The Revenue has been growing by 752.55% on average per year.
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.46%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y752.55%
Revenue growth 5YN/A
Sales Q2Q%-21.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUPW Yearly Revenue VS EstimatesJUPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUPW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUPW Price Earnings VS Forward Price EarningsJUPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUPW Per share dataJUPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JUPW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JUPITER WELLNESS INC

NASDAQ:JUPW (9/14/2023, 9:36:58 PM)

After market: 1.5 -0.02 (-1.32%)

1.52

+0.16 (+11.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-15 2023-08-15
Earnings (Next)11-13 2023-11-13
Inst Owners18.91%
Inst Owner Change0%
Ins Owners18.74%
Ins Owner Change0%
Market Cap41.28M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.92
P/FCF N/A
P/OCF N/A
P/B 7.28
P/tB 9.23
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.22
BVpS0.21
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.32%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.77
Altman-Z -4.45
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)52.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.13%
Revenue growth 3Y752.55%
Revenue growth 5YN/A
Sales Q2Q%-21.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.52%
OCF growth 3YN/A
OCF growth 5YN/A